Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05766384 · ClinicalTrials.gov registry record

Hyperpolarized 129Xe MRI Lung Health Cohort

A clinical trial of Healthy, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
260
Enrollment target
6
Study locations

NCT05766384 is a study of Healthy that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 260 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05766384, a study of Healthy, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
260 participants
Enrollment target
6
Study locations

Study Summary

A subset of young adults participating in the American Lung Association (ALA) Lung Health Cohort (LHC) will be imaged using Hyperpolarized 129Xe MRI to assess lung structure and function. Images will be used to improve the understanding of lung health and early lung abnormalities that may lead to chronic lung disease.

Conditions Studied

Interventions

  • DRUG Hyperpolarized Xe129

Study Locations (6)

Texas

  • Baylor College of Medicine - Houston
  • MD Anderson Cancer Center - Houston

Illinois

  • University of Illinois-Chicago - Chicago

Iowa

  • University of Iowa - Iowa City

Kansas

  • University of Kansas Medical Center - Kansas City

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2023-11-30
Est. Completion 2027-03-31

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT05766384

The ClinicalTrials.gov registry entry for NCT05766384 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Hyperpolarized Xe129 is the first listed.

NCT05766384 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Texas, Illinois, Iowa.

Frequently Asked Questions

What is clinical trial NCT05766384 about?

NCT05766384 is a clinical study titled "Hyperpolarized 129Xe MRI Lung Health Cohort". A subset of young adults participating in the American Lung Association (ALA) Lung Health Cohort (LHC) will be imaged using Hyperpolarized 129Xe MRI to assess lung structure and function. Images will be used to improve the understanding of lung health and early lung abnormalities that may lead to ch...

What is the current status of trial NCT05766384?

This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2023-11-30. Estimated completion is 2027-03-31.

What conditions does trial NCT05766384 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05766384?

The interventions under investigation include: Hyperpolarized Xe129 (DRUG).

Who is sponsoring clinical trial NCT05766384?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05766384 being conducted?

This trial has 6 study locations across Illinois, Iowa, Kansas, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.